In human post-mortem brain from PD cases, NLRP3 expression is elevated in mesencephalic neurons; furthermore, NLRP3 genetic polymorphisms are associated with downregulation of NLRP3 activity and reduced risk of PD (von Herrmann et al., 2018). The gene discussed is NLRP3; the disease is Parkinson disease.